30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Scivanta Medical Corp (SCVM)

Track

Stock chart
Ticker: SCVM Exchange: PNK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
CMD Investment Group, LLC
1 purchase — total 50,000 USD
Buy 22 Mar 2013
Value US$1,205,572.96 | Price 192.28 | Shares 81,899
Buy 22 Mar 2011
Value US$3,855,477.70 | Price 335.69 | Shares 75,978
Buy 9 Feb 2011
Value US$25,000.00 | Price 0.10 | Shares 250,000
Buy 5 Feb 2007
Value US$125,000.00 | Price 0.20 | Shares 625,000
Buy 5 Feb 2007
Value US$125,000.00 | Price 0.20 | Shares 625,000
Buy 25 Aug 2005
Value US$25,000.00 | Price 0.05 | Shares 500,000
Buy 25 Aug 2005
Value US$50,000.00 | Price 0.05 | Shares 1,000,000
Buy 25 Aug 2005
Value US$25,000.00 | Price 0.05 | Shares 500,000
Buy 25 Feb 2005
Value US$55,000.00 | Price 0.10 | Shares 550,000
Buy 25 Feb 2005
Value US$55,000.00 | Price 0.10 | Shares 550,000
Buy 14 May 2004
Value US$75,000.00 | Price 0.08 | Shares 937,500
Buy 14 May 2004
Value US$75,000.00 | Price 0.08 | Shares 937,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2013-03-27 2013-03-22 B Purchase CMD Investment Group, LLC Large shareholder
81,899 +34.2%
192.28
US$1,205,573 		81,899 +34.2% 192.28 US$1,205,573
2013-03-27 2011-03-22 B Purchase Nixon Wayne J. Large shareholder
75,978 -3.3%
335.69
US$3,855,478 		75,978 -3.3% 335.69 US$3,855,478
2013-03-27 2011-02-09 B Purchase Nixon Wayne J. Large shareholder
99,207 -6.8%
213.04
US$3,828,143 		99,207 -6.8% 213.04 US$3,828,143
2007-02-08 2007-02-05 B Purchase GIFFORD THOMAS S

EVP, CFO and Secretary

Executive Director Large shareholder
625,000 +19.3%
0.20
US$125,000 		625,000 +19.3% 0.20 US$125,000
2007-02-08 2007-02-05 B Purchase LAVANCE DAVID R JR

Chairman, President and CEO

Executive Director Large shareholder
625,000 +21.4%
0.20
US$125,000 		625,000 +21.4% 0.20 US$125,000
2005-08-29 2005-08-25 B Purchase LAVANCE DAVID R JR

Chairman, President & CEO

Executive Director Large shareholder
500,000 +22.6%
0.05
US$25,000 		500,000 +22.6% 0.05 US$25,000
2005-08-29 2005-08-25 B Purchase MOORE JOHN A Non-Executive Director
1,000,000 +600.2%
0.05
US$50,000 		1,000,000 +600.2% 0.05 US$50,000
2005-08-29 2005-08-25 B Purchase GIFFORD THOMAS S

EVP, CFO & Secretary

Executive Director Large shareholder
500,000 +19.8%
0.05
US$25,000 		500,000 +19.8% 0.05 US$25,000
2005-03-01 2005-02-25 B Purchase GIFFORD THOMAS S

EVP, CFO & Secretary

Executive Director Large shareholder
550,000 +34.3%
0.10
US$55,000 		550,000 +34.3% 0.10 US$55,000
2005-03-01 2005-02-25 B Purchase LAVANCE DAVID R JR

Chairman, President & CEO

Executive Director Large shareholder
550,000 +34.3%
0.10
US$55,000 		550,000 +34.3% 0.10 US$55,000
2005-09-29 2004-05-14 B Purchase GIFFORD THOMAS S

EVP, CFO and Secretary

Executive Director
937,500 +200.0%
0.08
US$75,000 		937,500 +200.0% 0.08 US$75,000
2005-09-29 2004-05-14 B Purchase LAVANCE DAVID R JR

Chairman, President & CEO

Executive Director
937,500 +200.0%
0.08
US$75,000 		937,500 +200.0% 0.08 US$75,000
Explore more

More insider trading research around Scivanta Medical Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America